EMOttawa Blog
  • Ottawa Handbook of Emergency Medicine
  • EMOttawa Podcast
  • Point-of-Care Echo
  • Grand Round Summaries
  • Journal Club
  • Commentary
  • Ultrasound
  • Infographics
  • Canadian TIA Score
  • EDI
  • Prehospital and Transport Medicine
  • Ottawa Acute Care Resources
  • About Us
Select Page
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.

Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.

by Hans Rosenberg | Nov 9, 2020 | Journal Club, Neurology

Methodology: 2/5 Usefulness: 2/5 Johnston SC, et al. N Engl J Med. 2020 Jul 16;383(3):207-217. Question and Methods: Multicentre, double-blind RCT of ASA vs Ticagrelor-ASA among 11016 patients with high-risk TIA or minor stroke for prevention of stroke/death within 30...
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

by Hans Rosenberg | Nov 19, 2018 | Journal Club, landmark, Neurology

Journal Club Summary Methodology Score: 3.5/5 Usefulness Score: 4/5 Johnston SC, et al. N Engl J Med. 2018 Jul 19;379(3):215-225 Editorial:  Antiplatelet Therapy after Ischemic Stroke or TIA. Question and Methods: This randomized, double-blind trial evaluated ASA +...

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

by emottawa | Oct 11, 2016 | Journal Club

Journal Club Summary Methodology Score: 5/5                    Usefulness Score:  3.5/5   Johnston SC, et al. N Engl J Med. 2016 Jul 7;375(1):35-43. Full Article   This large international double-blind double-dummy RCT across 33 countries and including 13,199 patients...
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Mission Statement

World-Class Emergency Medicine: To provide outstanding compassionate emergency care through practice-changing research and innovative medical education. For more about our department, visit us at EMOttawa.

Categories

Free Open Access Medical Education content by EMOttawa is under a Creative Commons Attribution-NonCommercial ShareAlike 4.0 International License.